1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-0065, NCT01169636
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 60 and over Sponsor: Other Protocol IDs: 2010-0991, NCT01371630
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: T1405, NCT00292695
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 0 to 65 Sponsor: Other Protocol IDs: 2009-0266, NCT01010217
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: DFCI Protocol No.: 10-057, NCT01181271
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-06-019, NCT01238159
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 13 and over Sponsor: Other Protocol IDs: SARCOMA0007, SU-03082011-7559, NCT01313884
|
|
8.
|
Phase: Phase II Type: Treatment Status: Approved-not yet active Age: Not specified Sponsor: Other Protocol IDs: 2008-0598, NCT01319981
|
|
9.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: UCBT01, NCT01328496
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: 2009-0796, NCT01329900
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: LMTG 11-02, NCT01333605
|
|
12.
|
Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2010-0708, NCT01363128
|
|
13.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011-0030, NCT01424982
|
|
14.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PLRG8 (OMB114361), 2010-023568-42, NCT01481272
|
|
15.
|
Phase: Phase II Type: Treatment Status: Approved-not yet active Age: 18 to 70 Sponsor: Other Protocol IDs: MC1184, NCI-2012-01061, NCT01670084
|
|
16.
|
Phase: Phase I Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: 2012-0183, NCT01590732
|